Addendum to clinical guideline 30 long-acting reversible contraception
The NICE surveillance programme reviewed the guideline on Long-acting reversible contraception (NICE clinical guideline 30) in 2011, and found changes to product licensing that affected the section of the guideline on progestogen-only subdermal implants. The full report can be found here: http://www...
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
London
National Institute for Health and Care Excellence (UK)
September 2014, 2014
|
Series: | Clinical guideline addendum
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references